BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 94   

Articles published

BIOL 0.900 -0.060 (-6.25%)
price chart
Company Shares of Biolase, Inc. (NASDAQ:BIOL) Drops by -10.48%
Biolase, Inc. (NASDAQ:BIOL) has dropped 10.48% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 2.17% in the last 4 weeks.
Biolase Inc Bearish Signal Schuler Jack W decreased Stake
Schuler Jack W has filled a SC 13D/A form regarding Biolase, Inc 0.960 +0.012 1.27% . Filing Link: 000119312515352173.
BIOLASE Inc (NASDAQ:BIOL) SVP / Chief Financial Officer David Dreyer ...
BIOLASE Inc (NASDAQ:BIOL) 0.938 0.00 0.00% 's SVP / Chief Financial Officer, David Dreyer, bought 5,000 shares of stock in the public company.
The Insider and SVP / Chief Financial Officer of BIOLASE Inc (NASDAQ:BIOL ...
Company Shares of Biolase, Inc. (NASDAQ:BIOL) Drops by -6.86%
Biolase, Inc. (NASDAQ:BIOL) has lost 6.86% during the past week and dropped 35.81% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 7.7%.
Three Highly Unusual Volume Spikes:Interphase Corporation (NASDAQ:INPH ...
Here, we look for stocks with a price and a simultaneous volume surge. Why monitor price-volume surges? Consider the following. When traders believe their indicators suggest a stock is about to break through a line of resistance some will act in ...
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
BIOLASE Inc (BIOL) news: Biolase management faces proxy fight  Seeking Alpha
Related articles »  
Biolase, Inc. (NASDAQ:BIOL) Short Interest Update
Biolase, Inc. (NASDAQ:BIOL) stated loss of 54,221 shares or 1.7% in the short interest. The short interest registered from 3,174,418 on September 15,2015 to 3,120,197 on September 30,2015.
BIOLASE Comments on Recent Decline in Stock Price
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office ...
Biolase Jumps on CEO Comments  Orange County Business Journal
Biolase: Why Your Dentist Is Short This Stock
... and I find myself in wonder of how major shareholders haven't forced aggressive action to spark a turnaround. I also find myself in a position to profit from all three.